1887

Abstract

Epstein–Barr virus (EBV) encodes at least 44 mature microRNAs (miRNAs), some of which are abundantly expressed in nasopharyngeal carcinoma cells. EBV-encoded miR-BART6 miRNA is known to undergo adenosine-to-inosine (A-to-I) RNA editing, which impacts on processing and function. Whether additional EBV miRNAs might be A-to-I edited remains to be determined. In this study, we have reported on A-to-I editing of EBV miR-BART3. The A-to-I editing enzyme was expressed abundantly in EBV-infected epithelial carcinoma cells. pri-miR-BART3 was found to be edited at four sites in these cells and in nasopharyngeal carcinoma samples. Whereas editing of the second site located within the seed region prevented the targeting of DICE1 mRNA, editing of the third site effectively crippled the biogenesis of mature miR-BART3. Thus, A-to-I editing perturbs biogenesis and targeting of miR-BART3 and may contribute to its differential expression and function in EBV-infected epithelial cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.056226-0
2013-12-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/12/2739.html?itemId=/content/journal/jgv/10.1099/vir.0.056226-0&mimeType=html&fmt=ahah

References

  1. Amoroso R., Fitzsimmons L., Thomas W. A., Kelly G. L., Rowe M., Bell A. I.. ( 2011;). Quantitative studies of Epstein–Barr virus-encoded microRNAs provide novel insights into their regulation. . J Virol 85:, 996–1010. [CrossRef][PubMed]
    [Google Scholar]
  2. Bahn J. H., Lee J. H., Li G., Greer C., Peng G., Xiao X.. ( 2012;). Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. . Genome Res 22:, 142–150. [CrossRef][PubMed]
    [Google Scholar]
  3. Bass B. L.. ( 2000;). Double-stranded RNA as a template for gene silencing. . Cell 101:, 235–238. [CrossRef][PubMed]
    [Google Scholar]
  4. Bass B. L.. ( 2002;). RNA editing by adenosine deaminases that act on RNA. . Annu Rev Biochem 71:, 817–846. [CrossRef][PubMed]
    [Google Scholar]
  5. Blow M. J., Grocock R. J., van Dongen S., Enright A. J., Dicks E., Futreal P. A., Wooster R., Stratton M. R.. ( 2006;). RNA editing of human microRNAs. . Genome Biol 7:, R27. [CrossRef][PubMed]
    [Google Scholar]
  6. Cai X., Schäfer A., Lu S., Bilello J. P., Desrosiers R. C., Edwards R., Raab-Traub N., Cullen B. R.. ( 2006;). Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. . PLoS Pathog 2:, e23. [CrossRef][PubMed]
    [Google Scholar]
  7. Chen S. J., Chen G. H., Chen Y. H., Liu C. Y., Chang K. P., Chang Y. S., Chen H. C.. ( 2010;). Characterization of Epstein–Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. . PLoS ONE 5:, e12745. [CrossRef][PubMed]
    [Google Scholar]
  8. Cheung S. T., Huang D. P., Hui A. B., Lo K. W., Ko C. W., Tsang Y. S., Wong N., Whitney B. M., Lee J. C.. ( 1999;). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein–Barr virus. . Int J Cancer 83:, 121–126. [CrossRef][PubMed]
    [Google Scholar]
  9. Choudhury Y., Tay F. C., Lam D. H., Sandanaraj E., Tang C., Ang B. T., Wang S.. ( 2012;). Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. . J Clin Invest 122:, 4059–4076. [CrossRef][PubMed]
    [Google Scholar]
  10. Choy E. Y. W., Kok K. H., Tsao S. W., Jin D. Y.. ( 2008a;). Utility of Epstein–Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs. . Gene Ther 15:, 191–202. [CrossRef][PubMed]
    [Google Scholar]
  11. Choy E. Y. W., Siu K. L., Kok K. H., Lung R. W. M., Tsang C. M., To K. F., Kwong D. L., Tsao S. W., Jin D. Y.. ( 2008b;). An Epstein–Barr virus-encoded microRNA targets PUMA to promote host cell survival. . J Exp Med 205:, 2551–2560. [CrossRef][PubMed]
    [Google Scholar]
  12. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., Thorley-Lawson D. A.. ( 2009;). Comprehensive profiling of Epstein–Barr virus microRNAs in nasopharyngeal carcinoma. . J Virol 83:, 2357–2367. [CrossRef][PubMed]
    [Google Scholar]
  13. Edwards R. H., Marquitz A. R., Raab-Traub N.. ( 2008;). Epstein–Barr virus BART microRNAs are produced from a large intron prior to splicing. . J Virol 82:, 9094–9106. [CrossRef][PubMed]
    [Google Scholar]
  14. Eggington J. M., Greene T., Bass B. L.. ( 2011;). Predicting sites of ADAR editing in double-stranded RNA. . Nat Commun 2:, 319. [CrossRef][PubMed]
    [Google Scholar]
  15. Gandy S. Z., Linnstaedt S. D., Muralidhar S., Cashman K. A., Rosenthal L. J., Casey J. L.. ( 2007;). RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. . J Virol 81:, 13544–13551. [CrossRef][PubMed]
    [Google Scholar]
  16. García-López J., Hourcade J. D., Del Mazo J.. ( 2013;). Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos. . Nucleic Acids Res 41:, 5483–5493. [CrossRef][PubMed]
    [Google Scholar]
  17. Gommans W. M.. ( 2012;). A-to-I editing of microRNAs: regulating the regulators?. Semin Cell Dev Biol 23:, 251–257. [CrossRef][PubMed]
    [Google Scholar]
  18. Gourzones C., Barjon C., Busson P.. ( 2012;). Host-tumor interactions in nasopharyngeal carcinomas. . Semin Cancer Biol 22:, 127–136. [CrossRef][PubMed]
    [Google Scholar]
  19. Huang D. P., Ho J. H., Poon Y. F., Chew E. C., Saw D., Lui M., Li C. L., Mak L. S., Lai S. H., Lau W. H.. ( 1980;). Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. . Int J Cancer 26:, 127–132. [CrossRef][PubMed]
    [Google Scholar]
  20. Iizasa H., Wulff B. E., Alla N. R., Maragkakis M., Megraw M., Hatzigeorgiou A., Iwakiri D., Takada K., Wiedmer A.. & other authors ( 2010;). Editing of Epstein–Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. . J Biol Chem 285:, 33358–33370. [CrossRef][PubMed]
    [Google Scholar]
  21. Kim N., Chae H. S., Oh S. T., Kang J. H., Park C. H., Park W. S., Takada K., Lee J. M., Lee W. K., Lee S. K.. ( 2007;). Expression of viral microRNAs in Epstein–Barr virus-associated gastric carcinoma. . J Virol 81:, 1033–1036. [CrossRef][PubMed]
    [Google Scholar]
  22. Lei T., Yuen K. S., Xu R., Tsao S. W., Chen H., Li M., Kok K. H., Jin D. Y.. ( 2013;). Targeting of DICE1 tumor suppressor by Epstein–Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. . Int J Cancer 133:, 79–87. [CrossRef][PubMed]
    [Google Scholar]
  23. Levanon E. Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., Fligelman Z. Y., Shoshan A., Pollock S. R.. & other authors ( 2004;). Systematic identification of abundant A-to-I editing sites in the human transcriptome. . Nat Biotechnol 22:, 1001–1005. [CrossRef][PubMed]
    [Google Scholar]
  24. Lo A. K. F., To K. F., Lo K. W., Lung R. W., Hui J. W., Liao G., Hayward S. D.. ( 2007;). Modulation of LMP1 protein expression by EBV-encoded microRNAs. . Proc Natl Acad Sci U S A 104:, 16164–16169. [CrossRef][PubMed]
    [Google Scholar]
  25. Lo A. K. F., Dawson C. W., Jin D. Y., Lo K. W.. ( 2012;). The pathological roles of BART miRNAs in nasopharyngeal carcinoma. . J Pathol 227:, 392–403. [CrossRef][PubMed]
    [Google Scholar]
  26. Luciano D. J., Mirsky H., Vendetti N. J., Maas S.. ( 2004;). RNA editing of a miRNA precursor. . RNA 10:, 1174–1177. [CrossRef][PubMed]
    [Google Scholar]
  27. Pall G. S., Hamilton A. J.. ( 2008;). Improved northern blot method for enhanced detection of small RNA. . Nat Protoc 3:, 1077–1084. [CrossRef][PubMed]
    [Google Scholar]
  28. Peng Z., Cheng Y., Tan B. C., Kang L., Tian Z., Zhu Y., Zhang W., Liang Y., Hu X.. & other authors ( 2012;). Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. . Nat Biotechnol 30:, 253–260. [CrossRef][PubMed]
    [Google Scholar]
  29. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grässer F. A., van Dyk L. F., Ho C. K., Shuman S.. & other authors ( 2005;). Identification of microRNAs of the herpesvirus family. . Nat Methods 2:, 269–276. [CrossRef][PubMed]
    [Google Scholar]
  30. Qiu J., Cosmopoulos K., Pegtel M., Hopmans E., Murray P., Middeldorp J., Shapiro M., Thorley-Lawson D. A.. ( 2011;). A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. . PLoS Pathog 7:, e1002193. [CrossRef][PubMed]
    [Google Scholar]
  31. Raab-Traub N.. ( 2012;). Novel mechanisms of EBV-induced oncogenesis. . Curr Opin Virol 2:, 453–458. [CrossRef][PubMed]
    [Google Scholar]
  32. Riley K. J., Rabinowitz G. S., Yario T. A., Luna J. M., Darnell R. B., Steitz J. A.. ( 2012;). EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. . EMBO J 31:, 2207–2221. [CrossRef][PubMed]
    [Google Scholar]
  33. Samuel C. E.. ( 2011;). Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. . Virology 411:, 180–193. [CrossRef][PubMed]
    [Google Scholar]
  34. Skalsky R. L., Corcoran D. L., Gottwein E., Frank C. L., Kang D., Hafner M., Nusbaum J. D., Feederle R., Delecluse H. J.. & other authors ( 2012;). The viral and cellular microRNA targetome in lymphoblastoid cell lines. . PLoS Pathog 8:, e1002484. [CrossRef][PubMed]
    [Google Scholar]
  35. Tao Q., Young L. S., Woodman C. B., Murray P. G.. ( 2006;). Epstein–Barr virus (EBV) and its associated human cancers–genetics, epigenetics, pathobiology and novel therapeutics. . Front Biosci 11:, 2672–2713. [CrossRef][PubMed]
    [Google Scholar]
  36. Umbach J. L., Cullen B. R.. ( 2009;). The role of RNAi and microRNAs in animal virus replication and antiviral immunity. . Genes Dev 23:, 1151–1164. [CrossRef][PubMed]
    [Google Scholar]
  37. Xing L., Kieff E.. ( 2007;). Epstein–Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. . J Virol 81:, 9967–9975. [CrossRef][PubMed]
    [Google Scholar]
  38. Xu D., Brumm K., Zhang L.. ( 2006;). The latent membrane protein 1 of Epstein–Barr virus (EBV) primes EBV latency cells for type I interferon production. . J Biol Chem 281:, 9163–9169. [CrossRef][PubMed]
    [Google Scholar]
  39. Yang W., Chendrimada T. P., Wang Q., Higuchi M., Seeburg P. H., Shiekhattar R., Nishikura K.. ( 2006;). Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. . Nat Struct Mol Biol 13:, 13–21. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.056226-0
Loading
/content/journal/jgv/10.1099/vir.0.056226-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error